Posts made in October, 2013

Patient Centric Analytics

Posted by Kelly Myers on Oct 22, 2013 in Background | 0 comments

Many new therapies are indicated for patients with a specific disease subtype.  The past 30 years of healthcare analytics have focused on targeting and segmenting physicians, facilities, and diseases.  Virtually all metrics in use today aggregate activity data (e.g. total procedures) to one of the above entities. These methods were appropriate when a general description of the disease was warranted.  These techniques fall short when there is a need to identify patients with a specific disease subtype.

Inflammatory Bowel Disease (IBD) Analysis

Recently we published work conducted in Inflammatory Bowel Disease[1] (IBD) that helps to demonstrate the value of Patient Centric Analysis (PCA).  Short-term medium to high dose corticosteroid (CS) therapy is an effective treatment for IBD.  Due to complications from long-term steroid (LTS) therapy no patients should be on medium to high dose LTS for more than 2 months continuous therapy.  An analysis of claims data sets identified 36,500 LTS IBD patients in a universe of 191,225 corticosteroid IBD patients (19.1% incidence).  The standard of care states that no patients with IBD should be on medium to high dose LTS.  A physician or facility centric analysis would not have been able to identify these LTS IBD patients who should be evaluated for other therapies.